These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 8554041)

  • 1. Postoperative radiotherapy of medulloblastoma. Impact of radiation quality on treatment outcome.
    Grabenbauer GG; Beck JD; Erhardt J; Seegenschmiedt MH; Seyer H; Thierauf P; Sauer R
    Am J Clin Oncol; 1996 Feb; 19(1):73-7. PubMed ID: 8554041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.
    Packer RJ; Sutton LN; Elterman R; Lange B; Goldwein J; Nicholson HS; Mulne L; Boyett J; D'Angio G; Wechsler-Jentzsch K
    J Neurosurg; 1994 Nov; 81(5):690-8. PubMed ID: 7931615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative neoadjuvant chemotherapy before radiotherapy as compared to immediate radiotherapy followed by maintenance chemotherapy in the treatment of medulloblastoma in childhood: results of the German prospective randomized trial HIT '91.
    Kortmann RD; Kühl J; Timmermann B; Mittler U; Urban C; Budach V; Richter E; Willich N; Flentje M; Berthold F; Slavc I; Wolff J; Meisner C; Wiestler O; Sörensen N; Warmuth-Metz M; Bamberg M
    Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):269-79. PubMed ID: 10661332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medulloblastoma: time-dose relationship based on a 30-year review.
    del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
    Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Medulloblastomas--the results after postoperative radiotherapy with and without adjuvant chemotherapy].
    Grabenbauer GG; Löhnert C; Erhardt J; Buchfelder M; Neubauer U; Beck JD; Reitz S; Seyer H; Thierauf P; Fietkau R
    Strahlenther Onkol; 1993 Apr; 169(4):213-21. PubMed ID: 8488458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The change in patterns of relapse in medulloblastoma.
    Tarbell NJ; Loeffler JS; Silver B; Lynch E; Lavally BL; Kupsky WJ; Scott RM; Sallan SE
    Cancer; 1991 Oct; 68(7):1600-4. PubMed ID: 1893359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protracted radiotherapy treatment duration in medulloblastoma.
    Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
    Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment results of adults and children with medulloblastoma NCI, Cairo University experience.
    Khalil EM
    J Egypt Natl Canc Inst; 2008 Jun; 20(2):175-86. PubMed ID: 20029474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: The International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study.
    Taylor RE; Bailey CC; Robinson K; Weston CL; Ellison D; Ironside J; Lucraft H; Gilbertson R; Tait DM; Walker DA; Pizer BL; Imeson J; Lashford LS; ;
    J Clin Oncol; 2003 Apr; 21(8):1581-91. PubMed ID: 12697884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.
    Taylor RE; Bailey CC; Robinson KJ; Weston CL; Walker DA; Ellison D; Ironside J; Pizer BL; Lashford LS
    Eur J Cancer; 2005 Mar; 41(5):727-34. PubMed ID: 15763649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary results of conformal radiation therapy for medulloblastoma.
    Merchant TE; Happersett L; Finlay JL; Leibel SA
    Neuro Oncol; 1999 Jul; 1(3):177-87. PubMed ID: 11550312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and late effects in medulloblastoma patients treated with craniospinal irradiation under three years old.
    Kiltie AE; Lashford LS; Gattamaneni HR
    Med Pediatr Oncol; 1997 May; 28(5):348-54. PubMed ID: 9121399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.
    Packer RJ; Gajjar A; Vezina G; Rorke-Adams L; Burger PC; Robertson PL; Bayer L; LaFond D; Donahue BR; Marymont MH; Muraszko K; Langston J; Sposto R
    J Clin Oncol; 2006 Sep; 24(25):4202-8. PubMed ID: 16943538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of radiation time and dose factors on outcome for childhood medulloblastoma.
    Back M; Ahern V; Berry M; Borg M; Sexton M; Cameron F; Stevens G; Allison R; Childs J; Barton M
    Australas Radiol; 2005 Aug; 49(4):298-303. PubMed ID: 16026436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment results for 149 medulloblastoma patients from one institution.
    Khafaga Y; Kandil AE; Jamshed A; Hassounah M; DeVol E; Gray AJ
    Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):501-6. PubMed ID: 8655373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medulloblastoma at the joint center for radiation therapy between 1968 and 1984. The influence of radiation dose on the patterns of failure and survival.
    Hughes EN; Shillito J; Sallan SE; Loeffler JS; Cassady JR; Tarbell NJ
    Cancer; 1988 May; 61(10):1992-8. PubMed ID: 3129177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an increased risk of spinal relapse in standard-risk medulloblastoma/primitive neuroectodermal tumor patients who receive only a reduced dose of craniospinal radiotherapy?
    Burcu A; Nazan Ç; Özgür Ö; Serra K; Mehmet K; Serap A; Bengü D; Canan V; Haldun Ö; Savaş K; Tuncer T; Taner A; Yeşim E; Ömer K; Yavuz A
    Childs Nerv Syst; 2018 Sep; 34(9):1657-1662. PubMed ID: 29868932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of medulloblastoma in children treated with reduced-dose radiation therapy plus adjuvant chemotherapy.
    Sirachainan N; Nuchprayoon I; Thanarattanakorn P; Pakakasama S; Lusawat A; Visudibhan A; Dhanachai M; Larbcharoensub N; Amornfa J; Shotelersuk K; Katanyuwong K; Tangkaratt S; Hongeng S
    J Clin Neurosci; 2011 Apr; 18(4):515-9. PubMed ID: 21310618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medulloblastoma: clinical and biologic aspects.
    Packer RJ; Cogen P; Vezina G; Rorke LB
    Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.